Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . July 29th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chronic Hepatitis C Virus - Ferritin a marker for treatment failure in those with hepatitis C virus
End-Stage Liver Disease - Interferon and ribavirin staunch hepatitis C after liver transplantation
Helicobacter - Ulcer bacteria identified in those with hepatitis C-related liver diseases
Hepatocellular Carcinoma - Viral infection supercedes familial genetics in risk for primary liver cancer
Fatty Liver - Weight loss may control steatosis in chronic hepatitis C
Hepatitis C - Nonexclusive HCV license granted to Merck
Legal Issues - Jury awards research hospital $200 million in punitive damages
Liver Cancer - Researchers create tiny cancer drug delivery device
Nosocomial Infection - Hospital urges hepatitis testing for some patients
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
